Clinical Trials in Jilin, Jilin
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Not Applicable
Indomethacin vs Diclofenac for Preventing PEP
PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441
Recruiting
Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Cardiac dysfunctionCoronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Phase 3
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
Advanced Non-squamous Non-small-cell Lung CancerMetastatic Non-Squamous Non-Small Cell Lung Cancer
Allist Pharmaceuticals, Inc.392 enrolled37 locationsNCT06416410
Recruiting
Not Applicable
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
Coronary Artery Disease
Ottawa Heart Institute Research Corporation176 enrolled13 locationsNCT03447938
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805